Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Sara Alkner"'
Autor:
A. Edvardsson, Lovisa Berg, Faisal Mahmood, Annika Mannerberg, Claus F. Behrens, Susanne Nørring Bekke, Sven Bäck, M. Kügele, Sara Alkner, Sofie Ceberg, Charlotte Thornberg
Publikováno v:
Kügele, M, Mannerberg, A, Nørring Bekke, S, Alkner, S, Berg, L, Mahmood, F, Thornberg, C, Edvardsson, A, Bäck, S Å J, Behrens, C F & Ceberg, S 2019, ' Surface guided radiotherapy (SGRT) improves breast cancer patient setup accuracy ', Journal of Applied Clinical Medical Physics, vol. 20, no. 9, pp. 61-68 . https://doi.org/10.1002/acm2.12700
Journal of Applied Clinical Medical Physics
Journal of Applied Clinical Medical Physics
Purpose: The purpose of the study was to investigate if surface guided radiotherapy (SGRT) can decrease setup deviations for tangential and locoregional breast cancer patients compared to conventional laser-based setup (LBS). Materials and Methods: B
Autor:
Sara Alkner, Christian Jamtheim Gustafsson, Minna Lerner, Lars E. Olsson, Joakim Medin, Carl Siversson
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Background Most studies on synthetic computed tomography (sCT) generation for brain rely on in-house developed methods. They often focus on performance rather than clinical feasibility. Therefore, the aim of this work was to validate sCT images gener
Autor:
L. M. Fredrik Leeb-Lundberg, Christian Ingvar, Ulrik Narbe, Carina Forsare, Kristina Lövgren, Sara Alkner, Mårten Fernö, Lisa Rydén, Martin Sjöström, Pär-Ola Bendahl
Publikováno v:
Breast Cancer Research and Treatment
Purpose According to the 2017 St Gallen surrogate definitions of the intrinsic subtypes, Ki67, progesterone receptor (PR) and Nottingham histological grade (NHG) are used for prognostic classification of estrogen receptor (ER) positive/HER2-negative
Publikováno v:
Cancer Research. 79:PD8-11
Background: Adjuvant locoregional radiotherapy (LRRT) reduces risk of locoregional failures (LRF) and improves survival for node positive breast cancer (BC) patients. However, LRRT increases the risk for toxicity as edema in the arm, lung cancer and
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 12, p e0226150 (2019)
PLoS ONE, Vol 14, Iss 12, p e0226150 (2019)
Background: Adjuvant endocrine treatment improves survival after estrogen receptor (ER) positive breast cancer. Recurrences occur, and most patients with metastatic breast cancer develop treatment resistance and incurable disease. An influential fact
Publikováno v:
APMIS. 126:746-754
Use of archived formalin-fixed paraffin-embedded (FFPE) tissue is a standard method for evaluation of proposed prognostic and predictive tumour markers. However, little is known of the preservation of biomarker expression in old FFPE tumour blocks. W
Autor:
Kristina Lövgren, Mårten Fernö, Martin Sjöström, Lisa Rydén, P-O Bendahl, Sara Alkner, Ulrik Narbe, Carina Forsare, Christian Ingvar, Flm Leeb-Lundberg
Publikováno v:
Cancer Research. 78:P1-07
Background: Estrogen receptor (ER) positive HER2-negative breast cancer comprises 75–80% of all breast cancer. This fraction is even higher (>90%) in invasive lobular carcinoma (ILC). According to the St Gallen surrogate definitions of the intrinsi
Publikováno v:
Journal of Applied Clinical Medical Physics
The aim of this study was to investigate potential dose reductions to the heart, left anterior descending coronary artery (LAD), and ipsilateral lung for left‐sided breast cancer using visually guided deep inspiration breath‐hold (DIBH) with the
Autor:
Per Karlsson, Jamila Adra, Elisabeth Kjellén, Sara Alkner, Fredrika Killander, Erik Holmberg, Dan Lundstedt, Mahnaz Haghanegi
Publikováno v:
International journal of radiation oncology, biology, physics. 105(2)
Purpose: To investigate incidence and location of locoregional recurrence (LRR) in patients who have received postoperative locoregional radiation therapy (LRRT) for primary breast cancer. LRR-position in relation to applied radiotherapy and the prim
Publikováno v:
European Journal of Cancer; 51(16), pp 2304-2313 (2015)
Aim A contralateral breast cancer (CBC) is today treated as an independent primary tumour, although recent data suggest risk and prognosis of CBC to be influenced by characteristics of and treatment given for the first tumour (BC1). We hereby investi